Detalhe da pesquisa
1.
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes.
Ann Hematol
; 103(2): 437-442, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38060001
2.
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 98(4): 628-638, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606718
3.
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea.
Blood
; 134(18): 1498-1509, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31515250
4.
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group.
Biol Blood Marrow Transplant
; 25(5): 932-940, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30579966
5.
JAK inhibitor treatment-resistant splenomegaly before transplantation in myelofibrosis: Splenectomy or radiotherapy?
Am J Hematol
; 99(5): 804-805, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482991
6.
A reappraisal of the benefit-risk profile of hydroxyurea in polycythemia vera: A propensity-matched study.
Am J Hematol
; 92(11): 1131-1136, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28699191
7.
A novel method using blinatumomab for efficient, clinical-grade expansion of polyclonal T cells for adoptive immunotherapy.
J Immunol
; 193(9): 4739-47, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25267972
8.
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Haematologica
; 99(5): 916-21, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24389309
9.
Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation.
Bone Marrow Transplant
; 59(6): 751-758, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402345
10.
Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience.
Bone Marrow Transplant
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773280
11.
Molecular prognostication for transplant decision making of patients with myelodysplastic syndromes: A retrospective single-center study.
Leuk Res
; 142: 107529, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820666
12.
Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant
; 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38491198
13.
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy.
Br J Haematol
; 161(5): 688-694, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23573950
14.
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer.
Curr Hematol Malig Rep
; 18(4): 105-112, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221411
15.
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT.
Bone Marrow Transplant
; 58(12): 1357-1367, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679647
16.
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera.
NEJM Evid
; 2(6): EVIDoa2200335, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38320126
17.
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis.
Blood Adv
; 6(6): 1855-1864, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130339
18.
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial.
Lancet Haematol
; 8(3): e175-e184, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476571
19.
A pilot study of the Histone-Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms.
Br J Haematol
; 150(4): 446-55, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20560970
20.
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis.
Blood Cancer J
; 10(10): 100, 2020 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33056979